A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.

West African journal of medicine

Volumn 21, Issue 2, 2002, Pages 83-86

  Idoko, J A ^a   Akinsete, L ^a   Abalaka, A D ^a   Keshinro, L B ^a   Dutse, L ^a   Onyenekwe, B ^a   Lhekwaba, A ^a   Njoku, O S ^a   Kehinde, M O ^a   Wambebe, C O ^a  

^a UNIVERSITY OF JOS   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NELFINAVIR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZALCITABINE; ZIDOVUDINE;

ANTIBIOTIC RESISTANCE; ARTICLE; CD4 LYMPHOCYTE COUNT; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; METHODOLOGY; MULTICENTER STUDY; NIGERIA; PERIPHERAL NEUROPATHY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; TREATMENT OUTCOME; VIRUS LOAD; WEIGHT GAIN;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DIARRHEA; DOUBLE-BLIND METHOD; DRUG RESISTANCE, MICROBIAL; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; MALE; NELFINAVIR; NIGERIA; PERIPHERAL NERVOUS SYSTEM DISEASES; QUALITY OF LIFE; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT OUTCOME; VIRAL LOAD; WEIGHT GAIN; ZALCITABINE; ZIDOVUDINE;

EID: 0036545789     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)